|Articles|April 30, 2021
Analysis of Bevacizumab by SEC–MALLS
Author(s)YMC Europe GmbH
In this application note, YMC’s dedicated SEC column for antibodies, YMC-SEC MAB, has been used to develop a method for bevacizumab using MALLS detection.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
PRP-Z2 Diquat and Paraquat Separation
2
International Day of Women and Girls in Science 2026: Inspiring the Next Generation of Women in Chromatography
3
Celebrating Women Advancing Science and Society in Chromatography
4
Waters Completes Combination with BD Biosciences and Diagnostic Solutions Businesses
5